Yvonne Greenstreet, Chief Operating Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 46,639 shares at $161.00 ($7.5M) on 2020-07-10, disclosed to the SEC on 2020-07-14.
Open-market sale of $7.5M ALNY by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ALNY | SELL | 2026-02-17 | $2.2M | — | Filing → |
| ALNY | SELL | 2026-01-14 | $3.5M | — | Filing → |
| ALNY | SELL | 2025-11-14 | $23.2M | — | Filing → |